{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:40:17Z","timestamp":1789191617379,"version":"build-2803163510"},"reference-count":162,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,1,10]]},"abstract":"<jats:p>Colorectal cancer is the second leading cause of mortality in the United States. In the United States, the cumulative lifetime risk of developing colorectal cancer for both men and women is 6%. Despite advances in the management of this disease, the 5-year survival rate in the United States in only 62%. Because only 38% of patients are diagnosed when the cancers are localized to the bowel wall, it is likely that widespread implementation of screening could significantly improve the outcome. Colorectal cancer screening is cost effective, irrespective of the methods used. In addition to currently available methods (fecal occult blood, flexible sigmoidoscopy, colonoscopy, and double contrast barium enema), computed tomographic colonography (virtual colonoscopy) and stool-based molecular screening are under development.<\/jats:p><jats:p>Four classes of chemopreventive compounds have demonstrated efficacy in reducing recurrent colorectal adenomas and\/or cancer in randomized, controlled trials. They are selenium, calcium carbonate, hormone replacement therapy, and nonsteroidal anti-inflammatory drugs. The mechanisms of action of nonsteroidal anti-inflammatory drugs include inhibition of the cyclooxygenase system as well as cyclooxygenase-independent effects. Considerable effort is being expended to define chemopreventive activity, optimal dose, administration schedule, and toxicity for the coxibs in adenoma recurrence prevention trials. The threshold for tolerating toxicities is very low in asymptomatic individuals at minimally increased risk for colorectal neoplasia.<\/jats:p>","DOI":"10.1200\/jco.2005.08.097","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T02:26:39Z","timestamp":1105064799000},"page":"378-391","source":"Crossref","is-referenced-by-count":165,"title":["Colorectal Cancer Prevention"],"prefix":"10.1200","volume":"23","author":[{"given":"Ernest T.","family":"Hawk","sequence":"first","affiliation":[{"name":"From the Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Bethesda, MD; and The University of Texas M. D. Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Levin","sequence":"additional","affiliation":[{"name":"From the Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Bethesda, MD; and The University of Texas M. D. Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"BIB1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.54.1.41"},{"key":"BIB3","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.1.8"},{"key":"BIB4","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50044"},{"key":"BIB5","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525,1998-532,","DOI":"10.1056\/NEJM198809013190901"},{"key":"BIB6","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(02)00047-6"},{"key":"BIB7","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90186-I"},{"key":"BIB8","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"BIB9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(99)01971-X"},{"key":"BIB10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27203"},{"key":"BIB11","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00298-1"},{"key":"BIB12","unstructured":"Sporn MB: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36:2699,1976-2702,"},{"key":"BIB13","doi-asserted-by":"crossref","unstructured":"Kelloff GJ, Boone CW, Crowell JA, et al: Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl 25:1,1996-14,","DOI":"10.1002\/(SICI)1097-4644(1996)25+<1::AID-JCB1>3.0.CO;2-4"},{"key":"BIB14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203053261002"},{"key":"BIB15","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90158-1"},{"key":"BIB16","doi-asserted-by":"crossref","unstructured":"Macrae FA, St John DJ: Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers and adenomas. Gastroenterology 82:891,1982-898,","DOI":"10.1016\/S0016-5085(82)80252-7"},{"key":"BIB17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305133281901"},{"key":"BIB18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)03386-7"},{"key":"BIB19","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.6.840"},{"key":"BIB20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)03430-7"},{"key":"BIB21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.1.29"},{"key":"BIB22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.19.1423"},{"key":"BIB24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432203"},{"key":"BIB26","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.53.1.44"},{"key":"BIB27","doi-asserted-by":"publisher","DOI":"10.1177\/096914130301000305"},{"key":"BIB28","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(80)73284-4"},{"key":"BIB29","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197912000-00001"},{"key":"BIB30","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920901)70:3+<1236::AID-CNCR2820701508>3.0.CO;2-4"},{"key":"BIB31","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)91551-5"},{"key":"BIB32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203053261001"},{"key":"BIB33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.20.1572"},{"key":"BIB34","doi-asserted-by":"crossref","unstructured":"Schoen RE, Pinsky RF, Weissfeld JL, et al: Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 290:41,2003-48,","DOI":"10.1001\/jama.290.1.41a"},{"key":"BIB35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08268-5"},{"key":"BIB36","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750026443"},{"key":"BIB37","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.23.1763"},{"key":"BIB38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292701"},{"key":"BIB39","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.22.1769"},{"key":"BIB40","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.155.1.3975415"},{"key":"BIB41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007203430301"},{"key":"BIB42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007203430302"},{"key":"BIB43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031618"},{"key":"BIB44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1713"},{"key":"BIB45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1772"},{"key":"BIB46","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.11.858"},{"key":"BIB47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012294"},{"key":"BIB48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07591-8"},{"key":"BIB50","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.10.697"},{"key":"BIB51","unstructured":"O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al: Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 8:314,2002-346,"},{"key":"BIB52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006153422401"},{"key":"BIB53","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199305000-00005"},{"key":"BIB54","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-12-199512150-00002"},{"key":"BIB55","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430160065007"},{"key":"BIB56","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914NC431_1"},{"key":"BIB57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810293391803"},{"key":"BIB58","doi-asserted-by":"publisher","DOI":"10.2165\/00024669-200302010-00003"},{"key":"BIB59","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.11.1598"},{"key":"BIB60","unstructured":"Villavicencio RT, Rex DK: Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 11:185,2000-193,"},{"key":"BIB61","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(02)00031-X"},{"key":"BIB62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012015"},{"key":"BIB63","doi-asserted-by":"publisher","DOI":"10.1007\/BF00666098"},{"key":"BIB64","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-000-0074-0"},{"key":"BIB65","doi-asserted-by":"crossref","unstructured":"Kelloff GJ, Johnson JR, Crowell JA, et al: Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol Biomarkers Prev 4:1,1995-10,","DOI":"10.1111\/j.1524-4741.1995.tb00250.x"},{"key":"BIB66","doi-asserted-by":"crossref","unstructured":"Kelloff GJ: Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res 78:199,2000-334,","DOI":"10.1016\/S0065-230X(08)61026-X"},{"key":"BIB67","unstructured":"Cancer Prevention Study II: The American Cancer Society Prospective Study. Stat Bull Metrop Insur Co 73:21,1992-29,"},{"key":"BIB68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112053252301"},{"key":"BIB69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509073331001"},{"key":"BIB70","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"BIB71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199407213310301"},{"key":"BIB72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004203421602"},{"key":"BIB73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004203421601"},{"key":"BIB74","unstructured":"Corpet DE, Pierre F: Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12:391,2003-400,"},{"key":"BIB75","doi-asserted-by":"publisher","DOI":"10.1126\/science.2296722"},{"key":"BIB76","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.5.953"},{"key":"BIB77","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.5.805"},{"key":"BIB78","doi-asserted-by":"publisher","DOI":"10.1038\/ng0995-64"},{"key":"BIB79","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80433-X"},{"key":"BIB80","unstructured":"Edelmann W, Umar A, Yang K, et al: The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res 60:803,2000-807,"},{"key":"BIB81","doi-asserted-by":"publisher","DOI":"10.1038\/ng0398-276"},{"key":"BIB82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400204"},{"key":"BIB83","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)00453-9"},{"key":"BIB84","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(90)90005-I"},{"key":"BIB85","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021735"},{"key":"BIB86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021633"},{"key":"BIB87","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/13.4.541"},{"key":"BIB88","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70305-1"},{"key":"BIB89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1994.tb02176.x"},{"key":"BIB90","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.8.1493"},{"key":"BIB91","doi-asserted-by":"publisher","DOI":"10.1007\/s003840050160"},{"key":"BIB92","unstructured":"Jacoby RF, Seibert K, Cole CE, et al: The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60:5040,2000-5044,"},{"key":"BIB93","unstructured":"Reddy BS, Hirose Y, Lubet R, et al: Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293,2000-297,"},{"key":"BIB94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006293422603"},{"key":"BIB95","doi-asserted-by":"crossref","unstructured":"Umar A, Viner JL, Richmond E, et al: Chemoprevention of colorectal carcinogenesis. Int J Clin Oncol 7:2,2002-26,","DOI":"10.1007\/s101470200001"},{"key":"BIB96","unstructured":"Faivre J, Bonithon-Kopp C: Effect of fibre and calcium supplementation on adenoma recurrence and growth. IARC Sci Publ 156:457,2002-461,"},{"key":"BIB97","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540240035027"},{"key":"BIB98","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00887-4"},{"key":"BIB99","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19821001)50:7<1434::AID-CNCR2820500733>3.0.CO;2-F"},{"key":"BIB100","doi-asserted-by":"publisher","DOI":"10.1007\/BF01072087"},{"key":"BIB101","unstructured":"Wynder EL: The epidemiology of large bowel cancer. Cancer Res 35:3388,1975-3394,"},{"key":"BIB102","unstructured":"Slattery ML: Diet, lifestyle, and colon cancer. Semin Gastrointest Dis 11:142,2000-146,"},{"key":"BIB103","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(96)00273-8"},{"key":"BIB104","unstructured":"Lamson DW, Brignall MS: Natural agents in the prevention of cancer. Part 1: Human chemoprevention trials. Altern Med Rev 6:7,2001-19,"},{"key":"BIB105","unstructured":"Lamson DW, Brignall MS: Natural agents in the prevention of cancer, part two: preclinical data and chemoprevention for common cancers. Altern Med Rev 6:167,2001-187,"},{"key":"BIB106","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.23.1760"},{"key":"BIB107","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.17.1290"},{"key":"BIB108","doi-asserted-by":"publisher","DOI":"10.1159\/000007480"},{"key":"BIB109","unstructured":"Malila N, Virtamo J, Virtanen M, et al: The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 8:489,1999-493,"},{"key":"BIB110","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008936214087"},{"key":"BIB111","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.15.1220"},{"key":"BIB112","unstructured":"Alberts DS, Martinez ME, Roe D, et al: Proving the bile acid hypothesis for colon carcinogenesis: Mature results from a phase III chemoprevention trial of ursodeoxycholic acid versus placebo to prevent colorectal adenoma recurrence. Proc Am Soc Clin Oncol 22:91,2003, (abstr 363)"},{"key":"BIB113","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199612002-00002"},{"key":"BIB114","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1976.10667225"},{"key":"BIB115","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420609"},{"key":"BIB116","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.10.864"},{"key":"BIB117","unstructured":"Clark LC, Hixson LJ, Combs GF, Jr., et al: Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2:41,1993-46,"},{"key":"BIB118","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049157"},{"key":"BIB119","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/66.6.1564S"},{"key":"BIB120","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/53.4.1093"},{"key":"BIB121","unstructured":"Bautista D, Obrador A, Moreno V, et al: Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 6:57,1997-61,"},{"key":"BIB122","unstructured":"Martinez ME, Willett WC: Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7:163,1998-168,"},{"key":"BIB123","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02813-0"},{"key":"BIB124","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"BIB125","doi-asserted-by":"publisher","DOI":"10.1016\/S1086-5802(16)31183-4"},{"key":"BIB126","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb140014.x"},{"key":"BIB127","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-9-199805010-00001"},{"key":"BIB128","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.517"},{"key":"BIB129","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199701000-00012"},{"key":"BIB130","unstructured":"Potter JD, Bostick RM, Grandits GA, et al: Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: The Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 5:779,1996-784,"},{"key":"BIB131","doi-asserted-by":"crossref","unstructured":"Nanda K, Bastian LA, Hasselblad V, et al: Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93:880,1999-888,","DOI":"10.1097\/00006250-199905001-00041"},{"key":"BIB132","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1701"},{"key":"BIB133","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.1.179"},{"key":"BIB134","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(74)80055-9"},{"key":"BIB135","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.13.1254"},{"key":"BIB136","unstructured":"Ristimaki A, Sivula A, Lundin J, et al: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62:632,2002-635,"},{"key":"BIB137","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01583-2"},{"key":"BIB138","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33580"},{"key":"BIB139","unstructured":"Khuri FR, Wu H, Lee JJ, et al: Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 7:861,2001-867,"},{"key":"BIB140","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.42.082301.164620"},{"key":"BIB141","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3406"},{"key":"BIB142","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.11397"},{"key":"BIB143","unstructured":"Waskewich C, Blumenthal RD, Li H, et al: Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Cancer Res 62:2029,2002-2033,"},{"key":"BIB144","unstructured":"Shureiqi I, Chen D, Lotan R, et al: 15-lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 60:6846,2000-6850,"},{"key":"BIB145","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1631086100"},{"key":"BIB146","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31890"},{"key":"BIB147","unstructured":"Burn J, Chapman PD, Bishop DT, et al: Results of the CAPP1 Study: Aspirin and resistant starch are beneficial in familial adenomatous polyposis. Fam Cancer 2:42,2003,"},{"key":"BIB149","doi-asserted-by":"publisher","DOI":"10.1089\/152460900318911"},{"key":"BIB150","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.6.857"},{"key":"BIB151","doi-asserted-by":"crossref","unstructured":"Sinicrope FA, Half EO, Morris JS, et al: Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in Familial Adenomatous Polyposis (FAP) patients. Cancer Epidemiol Biomarkers Prev 13:920,2004-927,","DOI":"10.1158\/1055-9965.920.13.6"},{"key":"BIB152","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3754"},{"key":"BIB153","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026130623186"},{"key":"BIB154","unstructured":"Corpet DE, Tache S: Ranking chemopreventive agents on rat colon carcinogenesis. IARC Sci Publ 156:381,2002-384,"},{"key":"BIB155","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(02)00055-9"},{"key":"BIB156","unstructured":"Corpet DE, Parnaud G, Delverdier M, et al: Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res 60:3160,2000-3164,"},{"key":"BIB157","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.23.1745"},{"key":"BIB158","doi-asserted-by":"publisher","DOI":"10.1038\/79534"},{"key":"BIB159","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19981123)78:5<629::AID-IJC17>3.0.CO;2-8"},{"key":"BIB160","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199903)24:3<177::AID-MC4>3.0.CO;2-6"},{"key":"BIB161","unstructured":"Armstrong WB, Kennedy AR, Wan XS, et al: Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev 9:43,2000-47,"},{"key":"BIB162","unstructured":"Armstrong WB, Kennedy AR, Wan XS, et al: Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin Cancer Res 6:4684,2000-4691,"},{"key":"BIB163","unstructured":"Lippman SM, Matrisian LM: Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res 6:4599,2000-4603,"},{"key":"BIB164","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-4-200202190-00005"},{"key":"BIB165","doi-asserted-by":"crossref","unstructured":"Schoen RE, Pinsky PF, Weissfeld JL, et al: Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 290:41,2003-48,","DOI":"10.1001\/jama.290.1.41a"},{"key":"BIB166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb02730.x"},{"key":"BIB167","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432211"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.08.097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T11:53:16Z","timestamp":1682941996000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.08.097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,10]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1,10]]}},"alternative-id":["10.1200\/JCO.2005.08.097"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.08.097","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,10]]}}}